Astrana Health Q3: Strong Revenue, Lower Profit
Update: 2025-11-08
Description
Astrana Healths Q3 results for 2025 showed robust revenue growth, surpassing Wall Streets expectations with a 95.6% year-over-year increase to $956 million. However, lower-than-anticipated profitability and reduced full-year guidance led to a negative market reaction. The company attributed the revenue surge to integrating Prospect Health and organic growth, but operating margins fell due to new business mix and integration costs. Despite profit lagging predictions, Astrana Health remains optimistic, citing stable core cost trends and partner demand. The company expects significant revenue and adjusted earnings boost in 2026 from delayed payer contract transitions, while acknowledging potential challenges in Medicaid and exchange markets due to new regulations.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
